Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Verweij-van Vught

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Immunology Letters|July 1, 1992
Murine ascitic fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodiesB J Appelmelk, A M Verweij-Van Vught, J J Maaskant, et al.
Journal of Medical Microbiology|May 1, 1983
K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse modelA M Verweij-van Vught, J F van den Bosch, F Namavar, et al.
Infection and Immunity|September 1, 1991
Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilisB R Otto, W R Verweij, M Sparrius, et al.
Agents and Actions|December 1, 1987
Influence of rosmarinic acid on opsonization and intracellular killing of Escherichia coli and Staphylococcus aureus by porcine and human polymorphonuclear leucocytesA M Verweij-van Vught, B J Appelmelk, A B Groeneveld, et al.
Microbial Pathogenesis|October 1, 1988
Comparison of monoclonal antibodies to the deeper core region of gram-negative lipopolysaccharide by means of polymyxin B inhibition studiesB J Appelmelk, A M Verweij-van Vught, J J Maaskant, et al.
Diabetes Care|January 1, 1990
Preservatives in insulin preparations impair leukocyte function. In vitro studyI van Faassen, A M Verweij-van Vught, M Z Lomecky-Janousek, et al.
Journal of Medical Microbiology|July 1, 1989
Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancerF Namavar, E B Theunissen, A M Verweij-Van Vught, et al.
European Journal of Clinical Microbiology|June 1, 1986
Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coliF Namavar, J A Kaan, A M Verweij-van Vught, et al.
Microbial Pathogenesis|October 1, 1988
Prevention of lethal endotoxemia in actinomycin D-sensitized mice by incubation of Salmonella minnesota R595 lipopolysaccharide with monoclonal antibodies to R595B J Appelmelk, A M Verweij-van Vught, H Brade, et al.
Journal of General Microbiology|November 1, 1993
Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different originsB J Appelmelk, J J Maaskant, A M Verweij-van Vught, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Immunology Letters|July 1, 1992
Murine ascitic fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodiesB J Appelmelk, A M Verweij-Van Vught, J J Maaskant, et al.
Journal of Medical Microbiology|May 1, 1983
K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse modelA M Verweij-van Vught, J F van den Bosch, F Namavar, et al.
Infection and Immunity|September 1, 1991
Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilisB R Otto, W R Verweij, M Sparrius, et al.
Agents and Actions|December 1, 1987
Influence of rosmarinic acid on opsonization and intracellular killing of Escherichia coli and Staphylococcus aureus by porcine and human polymorphonuclear leucocytesA M Verweij-van Vught, B J Appelmelk, A B Groeneveld, et al.
Microbial Pathogenesis|October 1, 1988
Comparison of monoclonal antibodies to the deeper core region of gram-negative lipopolysaccharide by means of polymyxin B inhibition studiesB J Appelmelk, A M Verweij-van Vught, J J Maaskant, et al.
Diabetes Care|January 1, 1990
Preservatives in insulin preparations impair leukocyte function. In vitro studyI van Faassen, A M Verweij-van Vught, M Z Lomecky-Janousek, et al.
Journal of Medical Microbiology|July 1, 1989
Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancerF Namavar, E B Theunissen, A M Verweij-Van Vught, et al.
European Journal of Clinical Microbiology|June 1, 1986
Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coliF Namavar, J A Kaan, A M Verweij-van Vught, et al.
Microbial Pathogenesis|October 1, 1988
Prevention of lethal endotoxemia in actinomycin D-sensitized mice by incubation of Salmonella minnesota R595 lipopolysaccharide with monoclonal antibodies to R595B J Appelmelk, A M Verweij-van Vught, H Brade, et al.
Journal of General Microbiology|November 1, 1993
Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different originsB J Appelmelk, J J Maaskant, A M Verweij-van Vught, et al.
Pageof 4